Clinical aspect and molecular mechanism of DNA aneuploidy in gastric cancers

Journal of Gastroenterology

Volumn 47, Issue 4, 2012, Pages 351-358

  Oki, Eiji ^a   Hisamatsu, Yuichi ^a   Ando, Koji ^a   Saeki, Hiroshi ^a   Kakeji, Yoshihiro ^a   Maehara, Yoshihiko ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

BubR1; DNA aneuploidy; Flow cytometry; Gastric cancer; Loss of heterozygosity; Mad2; Prognosis

Indexed keywords

DNA; PROTEIN P53;

ANEUPLOIDY; CHROMOSOMAL INSTABILITY; GENE AMPLIFICATION; GENE MUTATION; GENETIC ANALYSIS; HELICOBACTER INFECTION; HETEROZYGOSITY LOSS; HUMAN; MOLECULAR MECHANICS; ONCOGENE; PATHOGENESIS; PRIORITY JOURNAL; PROGNOSIS; REVIEW; STOMACH CARCINOMA;

ANEUPLOIDY; CALCIUM-BINDING PROTEINS; CELL CYCLE PROTEINS; CHROMOSOMAL INSTABILITY; DIPLOIDY; DNA, NEOPLASM; FLOW CYTOMETRY; GENES, P53; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; M PHASE CELL CYCLE CHECKPOINTS; MUTATION; PROGNOSIS; PROTEIN-SERINE-THREONINE KINASES; REPRESSOR PROTEINS; STOMACH NEOPLASMS;

EID: 84863086574     PISSN: 09441174     EISSN: 14355922     Source Type: Journal    
DOI: 10.1007/s00535-012-0565-4     Document Type: Review

References (105)

1. Yasui W, Oue N, Aung PP, Matsumura S, Shutoh M, Nakayama H. Molecular-pathological prognostic factors of gastric cancer: a review. Gastric Cancer. 2005;8(2):86-94. (Pubitemid 40655517)
2. Yasui W, Oue N, Ito R, Kuraoka K, Nakayama H. Search for new biomarkers of gastric cancer through serial analysis of gene expression and its clinical implications. Cancer Sci. 2004;95(5): 385-92. (Pubitemid 38832680)
3. Kim YH, Kim NG, Lim JG, Park C, Kim H. Chromosomal alterations in paired gastric adenomas and carcinomas. Am J Pathol. 2001;158(2):655-62. (Pubitemid 32158626)
4. Sugai T, Nakamura S, Uesugi N, Habano W, Yoshida T, Tazawa H, et al. Role of DNA aneuploidy, overexpression of p53 gene product, and cellular proliferation in the progression of gastric cancer. Cytometry. 1999;38(3):111-7. (Pubitemid 29300335)
5. Panani AD. Cytogenetic and molecular aspects of gastric cancer: clinical implications. Cancer Lett. 2008;266(2):99-115.
6. Terada R, Yasutake T, Yamaguchi E, Hisamatsu T, Nakamura S, Ayabe H, et al. Higher frequencies of numerical aberrations of chromosome 17 in primary gastric cancers are associated with lymph node metastasis. J Gastroenterol. 1999;34(1):11-7. (Pubitemid 29112330)
7. Kitayama Y, Igarashi H, Watanabe F, Maruyama Y, Kanamori M, Sugimura H. Nonrandom chromosomal numerical abnormality predicting prognosis of gastric cancer: a retrospective study of 51 cases using pathology archives. Lab Invest. 2003;83(9):1311-20. (Pubitemid 37140316)
8. Wu MS, Chang MC, Huang SP, Tseng CC, Sheu JC, Lin YW, et al. Correlation of histologic subtypes and replication error phenotype with comparative genomic hybridization in gastric cancer. Genes Chromosomes Cancer. 2001;30(1):80-6.
9. Hidaka S, Yasutake T, Kondo M, Takeshita H, Yano H, Haseba M, et al. Frequent gains of 20q and losses of 18q are associated with lymph node metastasis in intestinal-type gastric cancer. Anticancer Res. 2003;23(4):3353-7. (Pubitemid 36975435)
10. Koo SH, Jeong TE, Kang J, Kwon KC, Park JW, Noh SM. Prognostic implications for gastric carcinoma based on loss of heterozygosity genotypes correlation with clinicopathologic variables. Cancer Genet Cytogenet. 2004;153(1):26-31. (Pubitemid 39592125)
11. Suzuki S, Egami K, Sasajima K, Ghazizadeh M, Shimizu H, Watanabe H, et al. Comparative study between DNA copy number aberrations determined by quantitative microsatellite analysis and clinical outcome in patients with stomach cancer. Clin Cancer Res. 2004;10(9):3013-9. (Pubitemid 38619677)
12. Oki E, Zhao Y, Yoshida R, Egashira A, Ohgaki K, Morita M, et al. The difference in p53 mutations between cancers of the upper and lower gastrointestinal tract. Digestion. 2009;79(Suppl 1): 33-9.
13. Oki E, Kakeji Y, Baba H, Tokunaga E, Nakamura T, Ueda N, et al. Impact of loss of heterozygosity of encoding phosphate and tensin homolog on the prognosis of gastric cancer. J Gastroenterol Hepatol. 2006;21(5):814-8. (Pubitemid 43793276)
14. Oki E, Kakeji Y, Zhao Y, Yoshida R, Ando K, Masuda T, et al. Chemosensitivity and survival in gastric cancer patients with microsatellite instability. Ann Surg Oncol. 2009;16(9): 2510-5.
15. Lengauer C, Kinzler KW, Vogelstein B. Genetic instability in colorectal cancers. Nature. 1997;386(6625):623-7. (Pubitemid 27175430)
16. Falchetti M, Saieva C, Lupi R, Masala G, Rizzolo P, Zanna I, et al. Gastric cancer with high-level microsatellite instability: target gene mutations, clinicopathologic features, and long-term survival. Hum Pathol. 2008;39(6):925-32.
17. Lee HS, Choi SI, Lee HK, Kim HS, Yang HK, Kang GH, et al. Distinct clinical features and outcomes of gastric cancers with microsatellite instability. Mod Pathol. 2002;15(6):632-40. (Pubitemid 34666467)
18. Pinto M, Oliveira C, Machado JC, Cirnes L, Tavares J, Carneiro F, et al. MSI-L gastric carcinomas share the hMLH1 methylation status of MSI-H carcinomas but not their clinicopathological profile. Lab Invest. 2000;80(12):1915-23. (Pubitemid 32012759)
19. Wu CW, Chen GD, Jiang KC, Li AF, Chi CW, Lo SS, et al. A genome-wide study of microsatellite instability in advanced gastric carcinoma. Cancer. 2001;92(1):92-101. (Pubitemid 32623045)
20. Wu MS, Lee CW, Shun CT, Wang HP, Lee WJ, Chang MC, et al. Distinct clinicopathologic and genetic profiles in sporadic gastric cancer with different mutator phenotypes. Genes Chromosomes Cancer. 2000;27(4):403-11.
21. Cunningham JM, Christensen ER, Tester DJ, Kim CY, Roche PC, Burgart LJ, et al. Hypermethylation of the hMLH1 promoter in colon cancer with microsatellite instability. Cancer Res. 1998;58(15):3455-60. (Pubitemid 28371090)
22. Kang GH, Shim YH, Ro JY. Correlation of methylation of the hMLH1 promoter with lack of expression of hMLH1 in sporadic gastric carcinomas with replication error. Lab Invest. 1999; 79(7):903-9. (Pubitemid 29344503)
23. Oki E, Oda S, Maehara Y, Sugimachi K. Mutated gene-specific phenotypes of dinucleotide repeat instability in human colorectal carcinoma cell lines deficient in DNA mismatch repair. Oncogene. 1999;18(12):2143-7. (Pubitemid 29178583)
24. Thibodeau SN, French AJ, Cunningham JM, Tester D, Burgart LJ, Roche PC, et al. Microsatellite instability in colorectal cancer: different mutator phenotypes and the principal involvement of hMLH1. Cancer Res. 1998;58(8):1713-8. (Pubitemid 28215098)
25. Bevilacqua RA, Simpson AJ. Methylation of the hMLH1 promoter but no hMLH1 mutations in sporadic gastric carcinomas with high-level microsatellite instability. Int J Cancer. 2000; 87(2):200-3. (Pubitemid 30434345)
26. Fleisher AS, Esteller M, Wang S, Tamura G, Suzuki H, Yin J, et al. Hypermethylation of the hMLH1 gene promoter in human gastric cancers with microsatellite instability. Cancer Res. 1999;59(5):1090-5. (Pubitemid 29135970)
27. Leung SY, Yuen ST, Chung LP, Chu KM, Chan AS, Ho JC. hMLH1 promoter methylation and lack of hMLH1 expression in sporadic gastric carcinomas with high-frequency microsatellite instability. Cancer Res. 1999;59(1):159-64. (Pubitemid 29062972)
28. Sugai T, Habano W, Jiao YF, Suzuki M, Takagane A, Nakamura S. Analysis of genetic alterations associated with DNA diploidy, aneuploidy and multiploidy in gastric cancers. Oncology. 2005; 68(4-6):548-57. (Pubitemid 41160988)
29. Sinicrope FA, Rego RL, Halling KC, Foster N, Sargent DJ, La Plant B, et al. Prognostic impact of microsatellite instability and DNA ploidy in human colon carcinoma patients. Gastroenterology. 2006;131(3):729-37. (Pubitemid 44307064)
30. Tang R, Changchien CR, Wu MC, Fan CW, Liu KW, Chen JS, et al. Colorectal cancer without high microsatellite instability and chromosomal instability - an alternative genetic pathway to human colorectal cancer. Carcinogenesis. 2004;25(5):841-6. (Pubitemid 38618539)
31. Toft NJ, Curtis LJ, Sansom OJ, Leitch AL, Wyllie AH, te Riele H, et al. Heterozygosity for p53 promotes microsatellite instability and tumorigenesis on a Msh2 deficient background. Oncogene. 2002;21(41):6299-306.
32. Bignold LP, Coghlan B, Jersmann H. David Paul Hansemann: chromosomes and the origin of the cancerous features of tumor cells. Cell Oncol. 2009;31(1):61.
33. Pihan GA, Doxsey SJ. The mitotic machinery as a source of genetic instability in cancer. Semin Cancer Biol. 1999;9(4): 289-302. (Pubitemid 29429993)
34. Kawauchi S, Furuay T, Uchiyama T, Adachi A, Okada T, Nakao M, et al. Genomic instability and DNA ploidy are linked to DNA copy number aberrations of 8p23 and 22q11.23 in gastric cancers. Int J Mol Med. 2010;26(3):333-9.
35. Brito MJ, Filipe MI, Williams GT, Thompson H, Ormerod MG, Titley J. DNA ploidy in early gastric carcinoma (T1): a flow cytometric study of 100 European cases. Gut. 1993;34(2):230-4. (Pubitemid 23049118)
36. Kim JM, Lee DK, Kim YK, Baik SK, Lee CI, Kwon SO, et al. DNA analysis by flow cytometry in early gastric cancer. Korean J Intern Med. 1997;12(2):137-43.
37. Osterheld MC, Caron L, Demierre M, Laurini R, Bosman FT. DNA-ploidy in advanced gastric carcinoma is less heterogeneous than in early gastric cancer. Cell Oncol. 2004;26(1-2): 21-9. (Pubitemid 39108240)
38. Sasaki O, Soejima K, Haraguchi Y. DNA ploidy in undifferentiated carcinomas of the human stomach-with special reference to its heterogeneity and the relation between its intratumor distribution pattern and prognosis. In Vivo. 1993;7(4):363-7.
39. Liang Y, Zhong Z, Huang Y, Deng W, Cao J, Tsao G, et al. Stem-like cancer cells are inducible by increasing genomic instability in cancer cells. J Biol Chem. 2009;285(7):4931-40.
40. Kusumbe AP, Bapat SA. Cancer stem cells and aneuploid populations within developing tumors are the major determinants of tumor dormancy. Cancer Res. 2009;69(24):9245-53.
41. Petrova AS, Subrichina GN, Tschistjakova OV, Lukina TA, Weiss H, Wildner G. Flow cytofluorometry, cytomorphology and histology in gastric carcinoma. Oncology. 1980;37(5): 318-24.
42. Omejc M, Repse S, Bracko M. Is DNA aneuploidy a prognostic factor in gastric cancer? Acta Chir Hung. 1997;36(1-4):266-9.
43. Lee KH, Lee JS, Suh C, Ahn MJ, Kim SW, Doh BS, et al. DNA flow cytometry of stomach cancer. Prospective correlation with clinicopathologic findings. Cancer. 1993;72(6):1819-26. (Pubitemid 23262105)
44. Kim JY, Cho HJ. DNA ploidy patterns in gastric adenocarcinoma. J Korean Med Sci. 2000;15(2):159-66.
45. Oda N, Tsujino T, Tsuda T, Yoshida K, Nakayama H, Yasui W, et al. DNA ploidy pattern and amplification of ERBB and ERBB2 genes in human gastric carcinomas. Virchows Arch B Cell Pathol Incl Mol Pathol. 1990;58(4):273-7. (Pubitemid 20098353)
46. Tosi P, Leoncini L, Cintorino M, Vindigni C, Minacci C, Nuti S, et al. Flow cytometric analysis of DNA ploidy pattern from deparaffinized formalin-fixed gastric cancer tissue. Int J Cancer. 1988;42(6):868-71. (Pubitemid 19012916)
47. Nanus DM, Kelsen DP, Niedzwiecki D, Chapman D, Brennan M, Cheng E, et al. Flow cytometry as a predictive indicator in patients with operable gastric cancer. J Clin Oncol. 1989;7(8): 1105-12. (Pubitemid 19196535)
48. Sasaki O, Kido K, Nagahama S. DNA ploidy, Ki-67 and p53 as indicators of lymph node metastasis in early gastric carcinoma. Anal Quant Cytol Histol. 1999;21(1):85-8. (Pubitemid 29097939)
49. Odegaard S, Hostmark J, Skagen DW, Schrumpf E, Laerum OD. Flow cytometric DNA studies in human gastric cancer and polyps. Scand J Gastroenterol. 1987;22(10):1270-6. (Pubitemid 18031903)
50. Yasa MH, Bektas A, Yukselen V, Akbulut H, Camci C, Ormeci N. DNA analysis and DNA ploidy in gastric cancer and gastric precancerous lesions. Int J Clin Pract. 2005;59(9):1029-33.
51. Belessi CJ, Parasi AS, Manioudaki HS, Laoutaris NP, Legakis NC, Peros GT, et al. Prognostic impact of DNA ploidy pattern, S-phase fraction (SPF), and proliferating cell nuclear antigen (PCNA) in patients with primary gastric lymphoma. J Surg Oncol. 2003;82(4):247-55. (Pubitemid 36389918)
52. Fernandez F, Rodriguez-Sanjuan JC, Mayorga M, Llorca J, Garcia RA, Trugeda S, et al. Prognostic value of flow cytometry in surgically treated primary gastric lymphoma. Rev Esp Enferm Dig. 2006;98(11):817-27. (Pubitemid 350259111)
53. Doak SH. Aneuploidy in upper gastro-intestinal tract cancers - a potential prognostic marker? Mutat Res. 2008;651(1-2):93-104.
54. Sanchez-Perez I, Garcia Alonso P, Belda Iniesta C. Clinical impact of aneuploidy on gastric cancer patients. Clin Transl Oncol. 2009;11(8):493-8.
55. Ohyama S, Yonemura Y, Miyazaki I. Prognostic value of S-phase fraction and DNA ploidy studied with in vivo administration of bromodeoxyuridine on human gastric cancers. Cancer. 1990;65(1):116-21. (Pubitemid 20026821)
56. Sakusabe M, Kodama M, Sato Y, Kikuchi T, Koyama K. Clinical significance of DNA ploidy pattern in stage III gastric cancer. World J Surg. 1996;20(1):27-31. (Pubitemid 26006193)
57. Shen KL, Chu CH. DNA ploidy and biologic aggressiveness of gastric adenocarcinoma in Chinese. World J Surg. 1994;18(3): 433-9. discussion 439-40.
58. Nesi G, Bruno L, Saieva C, Caldini A, Girardi LR, Zanna I, et al. DNA ploidy and S-phase fraction as prognostic factors in surgically resected gastric carcinoma: a 7-year prospective study. Anticancer Res. 2007;27(6C):4435-41.
59. Abad M, Ciudad J, Rincon MR, Silva I, Paz-Bouza JI, Lopez A, et al. DNA aneuploidy by flow cytometry is an independent prognostic factor in gastric cancer. Anal Cell Pathol. 1998; 16(4):223-31. (Pubitemid 28378278)
60. Santoro E, Carboni M, Catarci M, Carlini M, Carboni F, Zupi G, et al. DNA ploidy, proliferative index and EGF-R status in 130 cases of resected gastric cancer - A multivariate analysis. Hepatogastroenterology. 1997;44(15):826-37. (Pubitemid 27281128)
61. Wyatt JI, Quirke P, Ward DC, Clayden AD, Dixon MF, Johnston D, et al. Comparison of histopathological and flow cytometric parameters in prediction of prognosis in gastric cancer. J Pathol. 1989;158(3):195-201. (Pubitemid 19185436)
62. Setala LP, Nordling S, Kosma VM, Lipponen PK, Eskelinen MJ, Hollmen SM, et al. Comparison of DNA ploidy and S-phase fraction with prognostic factors in gastric cancer. Anal Quant Cytol Histol. 1997;19(6):524-32. (Pubitemid 28009389)
63. Thoma CR, Toso A, Meraldi P, Krek W. Mechanisms of aneuploidy and its suppression by tumour suppressor proteins. Swiss Med Wkly. 2011;141:w13170.
64. Mimori K, Inoue H, Alder H, Ueo H, Tanaka Y, Mori M. Mutation analysis of hBUB1, human mitotic checkpoint gene in multiple carcinomas. Oncol Rep. 2001;8(1):39-42. (Pubitemid 33758197)
65. Ando K, Kakeji Y, Kitao H, Iimori M, Zhao Y, Yoshida R, et al. High expression of BUBR1 is one of the factors for inducing DNA aneuploidy and progression in gastric cancer. Cancer Sci. 2010;101(3):639-45.
66. Kim HS, Park KH, Kim SA, Wen J, Park SW, Park B, et al. Frequent mutations of human Mad2, but not Bub1, in gastric cancers cause defective mitotic spindle checkpoint. Mutat Res. 2005;578(1-2):187-201. (Pubitemid 41395324)
67. Grabsch HI, Askham JM, Morrison EE, Pomjanski N, Lickvers K, Parsons WJ, et al. Expression of BUB1 protein in gastric cancer correlates with the histological subtype, but not with DNA ploidy or microsatellite instability. J Pathol. 2004;202(2): 208-14. (Pubitemid 38208658)
68. Grabsch H, Takeno S, Parsons WJ, Pomjanski N, Boecking A, Gabbert HE, et al. Overexpression of the mitotic checkpoint genes BUB1, BUBR1, and BUB3 in gastric cancer-association with tumour cell proliferation. J Pathol. 2003;200(1):16-22. (Pubitemid 36592631)
69. Davenport J, Harris LD, Goorha R. Spindle checkpoint function requires Mad2-dependent Cdc20 binding to the Mad3 homology domain of BubR1. Exp Cell Res. 2006;312(10):1831-42. (Pubitemid 43776003)
70. Wu CW, Chi CW, Huang TS. Elevated level of spindle checkprotein MAD2 correlates with cellular mitotic arrest, but not with aneuploidy and clinicopathological characteristics in gastric cancer. World J Gastroenterol. 2004;10(22):3240-4.
71. Sakakura C, Hagiwara A, Yasuoka R, Fujita Y, Nakanishi M, Masuda K, et al. Tumour-amplified kinase BTAK is amplified and overexpressed in gastric cancers with possible involvement in aneuploid formation. Br J Cancer. 2001;84(6):824-31. (Pubitemid 32275658)
72. Abdel-Wahab M, Attallah AM, Elshal MF, Abdel-Raouf M, Zalata KR, el-Ghawalby N, et al. Cellular proliferation and ploidy of the gastric mucosa: the role of Helicobacter pylori. Hepatogastroenterology. 1997;44(15):880-5. (Pubitemid 27281136)
73. Melato M, Sidari L, Rizzardi C, Kovac D, Stimac D, Baxa P, et al. Gastric epithelium proliferation in early Hp? and Hpgastritis: a flow cytometry study. Anticancer Res. 2001;21(2B): 1347-53.
74. Nardone G, Staibano S, Rocco A, Mezza E, D'Armiento FP, Insabato L, et al. Effect of Helicobacter pylori infection and its eradication on cell proliferation, DNA status, and oncogene expression in patients with chronic gastritis. Gut. 1999;44(6): 789-99. (Pubitemid 29244213)
75. Rocco A, Staibano S, Ottini L, Mezza E, Somma P, Mariani-Costantini R, et al. Is there a link between environmental factors and a genetic predisposition to cancer? A lesson from a familial cluster of gastric cancers. Eur J Cancer. 2003;39(11):1619-24. (Pubitemid 36829203)
76. Williams L, Somasekar A, Davies DJ, Cronin J, Doak SH, Alcolado R, et al. Aneuploidy involving chromosome 1 may be an early predictive marker of intestinal type gastric cancer. Mutat Res. 2009;669(1-2):104-11.
77. Targa AC, Cesar AC, Cury PM, Silva AE. Apoptosis in different gastric lesions and gastric cancer: relationship with Helicobacter pylori, overexpression of p53 and aneuploidy. Genet Mol Res. 2007;6(3):554-65. (Pubitemid 350096890)
78. Chan AO, Peng JZ, Lam SK, Lai KC, Yuen MF, Cheung HK, et al. Eradication of Helicobacter pylori infection reverses E-cadherin promoter hypermethylation. Gut. 2006;55(4):463-8.
79. Machado JC, Oliveira C, Carvalho R, Soares P, Berx G, Caldas C, et al. E-cadherin gene (CDH1) promoter methylation as the second hit in sporadic diffuse gastric carcinoma. Oncogene. 2001;20(12):1525-8. (Pubitemid 32291203)
80. Guilford P, Hopkins J, Harraway J, McLeod M, McLeod N, Harawira P, et al. E-cadherin germline mutations in familial gastric cancer. Nature. 1998;392(6674):402-5. (Pubitemid 28168738)
81. Humar B, Blair V, Charlton A, More H, Martin I, Guilford P. E-cadherin deficiency initiates gastric signet-ring cell carcinoma in mice and man. Cancer Res. 2009;69(5):2050-6.
82. Chan AO, Lam SK, Wong BC, Wong WM, Yuen MF, Yeung YH, et al. Promoter methylation of E-cadherin gene in gastric mucosa associated with Helicobacter pylori infection and in gastric cancer. Gut. 2003;52(4):502-6. (Pubitemid 36363400)
83. Dong CX, Deng DJ, Pan KF, Zhang L, Zhang Y, Zhou J, et al. Promoter methylation of p16 associated with Helicobacter pylori infection in precancerous gastric lesions: a populationbased study. Int J Cancer. 2009;124(2):434-9.
84. Duensing A, Duensing S. Guilt by association? p53 and the development of aneuploidy in cancer. Biochem Biophys Res Commun. 2005;331(3):694-700. (Pubitemid 40615499)
85. Ikeguchi M, Saito H, Kondo A, Tsujitani S, Maeta M, Kaibara N. Mutated p53 protein expression and proliferative activity in advanced gastric cancer. Hepatogastroenterology. 1999;46(28): 2648-53. (Pubitemid 29454160)
86. Karaman A, Kabalar ME, Binici DN, Ozturk C, Pirim I. Genetic alterations in gastric precancerous lesions. Genet Couns. 2011;21(4):439-50.
87. Saeki H, Kitao H, Yoshinaga K, Nakanoko T, Kubo N, Kakeji Y, et al. Copy-neutral loss of heterozygosity at the p53 locus in carcinogenesis of esophageal squamous cell carcinomas associated with p53 mutations. Clin Cancer Res. 2011;17(7): 1731-40.
88. Jiao YF, Sugai T, Suzuki M, Uesugi N, Habano W, Nakamura S, et al. Application of the crypt isolation technique to the flow cytometric analysis of DNA content in gastric carcinoma. Hum Pathol. 2004;35(5):587-93. (Pubitemid 38656944)
89. Kitayama Y, Sugimura H, Tanaka M, Nakamura S, Kino I. Expression of p53 and flow cytometric DNA analysis of isolated neoplastic glands of the stomach: an application of the gland isolation method. Virchows Arch. 1995;426(6):557-62.
90. Lapenna S, Giordano A. Cell cycle kinases as therapeutic targets for cancer. Nat Rev Drug Discov. 2009;8(7):547-66.
91. Korenaga D, Okamura T, Saito A, Baba H, Sugimachi K. DNA ploidy is closely linked to tumor invasion, lymph node metastasis, and prognosisinclinical gastric cancer. Cancer. 1988;62(2):309-13.
92. Korenaga D, Okamura T, Sugimachi K, Inokuchi K. Prognostic study of intramucosal carcinoma of the stomach with DNA aneuploidy. Jpn J Surg. 1985;15(6):443-8. (Pubitemid 16168851)
93. Sasaki K, Takahashi M, Hashimoto T, Kawachnino K. Flow cytometric DNA measurement of gastric cancers. Clinico-pathological implication of DNA ploidy. Pathol Res Pract. 1989;184(6):561-6.
94. Yonemura Y, Ooyama S, Sugiyama K, Kamata T, De Aretxabala X, Kimura H, et al. Retrospective analysis of the prognostic significance of DNA ploidy patterns and S-phase fraction in gastric carcinoma. Cancer Res. 1990;50(3):509-14. (Pubitemid 20054170)
95. Baretton G, Carstensen O, Schardey M, Lohrs U. DNA-ploidy and survival in gastric carcinomas: a flow-cytometric study. Virchows Arch A Pathol Anat Histopathol. 1991;418(4):301-9.
96. Haraguchi M, Watanabe A, Moriguchi S, Korenaga D, Maehara Y, Okamura T, et al. DNA ploidy is a major prognostic factor in advanced gastric carcinoma - univariate and multivariate analysis. Surgery. 1991;110(5):814-9.
97. Noguchi Y, Tsuburaya A, Makino T, Fukuzawa K, Nomura K, Yoshikawa T, et al. Predictive value of c-erbB-2 and DNA ploidy patterns in gastric carcinoma recurrence. Int Surg. 1993;78(2):107-11. (Pubitemid 23192272)
98. D'Agnano I, D'Angelo C, Savarese A, Carlini M, Garofalo A, Bottari L, et al. DNA ploidy, proliferative index, and epidermal growth factor receptor: expression and prognosis in patients with gastric cancers. Lab Invest. 1995;72(4):432-8.
99. Flyger HL, Christensen IJ, Thorup J, Hakansson TU, Norgaard T. DNA aneuploidy in gastric carcinoma. Flow cytometric data related to survival, location, and histopathologic findings. Scand J Gastroenterol. 1995;30(3):258-64.
100. Mizunuma H, Tsuchiya A, Ando Y, Kikuchi Y, Abe R. Flow cytometric DNA analysis of gastric cancer that is invading the muscularis propria. Eur J Surg. 1996;162(11):889-94.
101. Fujimaki E, Sasaki K, Nakano O, Chiba S, Tazawa H, Yamashiki H, et al. DNA ploidy heterogeneity in early and advanced gastric cancers. Cytometry. 1996;26(2):131-6. (Pubitemid 26238186)
102. Wang Z, Ikeguchi M, Maeta M, Kaibara N. The correlation between the expression of p53 protein and DNA ploidy in patients with gastric cancer that has invaded the serosa. Anticancer Res. 1997;17(5A):3701-5. (Pubitemid 27522349)
103. Hirose K, Iida A, Yamaguchi A, Onchi H, Awata H, Katayama K, et al. Prognostic value of DNA ploidy and proliferating cell nuclear antigen in gastric cancer. Oncology. 1998;55(4):300-6. (Pubitemid 28279671)
104. Furuya T, Uchiyama T, Murakami T, Adachi A, Kawauchi S, Oga A, et al. Relationship between chromosomal instability and intratumoral regional DNA ploidy heterogeneity in primary gastric cancers. Clin Cancer Res. 2000;6(7):2815-20. (Pubitemid 30482122)
105. Lee JH, Noh SH, Lee KY, Choi SH, Min JS. DNA ploidy patterns in advanced gastric carcinoma; is it a clinically applicable prognosticator? Hepatogastroenterology. 2001;48(42):1793-6. (Pubitemid 34003529)